Executive Wealth Management, LLC Amgen Inc Transaction History

Executive Wealth Management, LLC

$1.16 Billion
Q3 2024

A detailed history of Executive Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Executive Wealth Management, LLC holds 24,456 shares of AMGN stock, worth $6.44 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

24,456

Previous 24,456 -0.0%

Holding current value

$6.44 Million

Previous $7.88 Million -0.0%

% of portfolio

0.68%

Previous 1.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$309.38 - $337.38 $7.57 Million - $8.25 Million	24,456 New	24,456 $7.88 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $1.36 Million - $1.65 Million	-5,070 Reduced 16.53%	25,605 $7.28 Million
Q4 2023 Jan 26, 2024	BUY	$255.7 - $288.46 $113,019 - $127,499	442 Added 1.46%	30,675 $8.84 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $158,739 - $197,079	726 Added 2.46%	30,233 $8.13 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $917,504 - $1.08 Million	4,282 Added 16.98%	29,507 $6.55 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $1.16 Million - $1.42 Million	-5,153 Reduced 16.96%	25,225 $6.1 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $5.65 Million - $7.18 Million	24,674 Added 432.57%	30,378 $7.98 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $4.4 Million - $4.96 Million	-19,586 Reduced 77.45%	5,704 $5.7 Million
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $2.03 Million - $2.26 Million	-8,785 Reduced 25.78%	25,290 $6.15 Million
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $865,677 - $957,666	3,948 Added 13.1%	34,075 $8.24 Million
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $275,846 - $315,681	1,387 Added 4.83%	30,127 $6.78 Million
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $59,223 - $69,387	279 Added 0.98%	28,740 $6.11 Million
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $5.64 Million - $6.25 Million	24,125 Added 556.39%	28,461 $6.94 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $308,898 - $359,971	1,392 Added 47.28%	4,336 $1.08 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $97,154 - $115,693	449 Added 18.0%	2,944 $677,000
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $60,305 - $67,064	257 Added 11.48%	2,495 $634,000
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $280,692 - $344,448	-1,419 Reduced 38.8%	2,238 $527,000
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $321,653 - $426,600	-1,765 Reduced 32.55%	3,657 $741,000
Q4 2019 Jan 23, 2020	BUY	$189.21 - $243.2 $1.03 Million - $1.32 Million	5,422 New	5,422 $1.31 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $1.19 Million - $1.42 Million	-6,815 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $125,691 - $147,339	754 Added 12.44%	6,815 $1.26 Million
Q1 2019 May 02, 2019	SELL	$180.87 - $203.88 $125,342 - $141,288	-693 Reduced 10.26%	6,061 $1.15 Million
Q4 2018 Feb 19, 2019	BUY	$178.4 - $208.25 $1.2 Million - $1.41 Million	6,754 New	6,754 $1.32 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Executive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Executive Wealth Management, LLC with notifications on news.

Account

Executive Wealth Management, LLC Amgen Inc Transaction History